Form 8-K - Current report:
SEC Accession No. 0001193125-25-275721
Filing Date
2025-11-12
Accepted
2025-11-12 06:16:08
Documents
20
Period of Report
2025-11-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d80000d8k.htm   iXBRL 8-K 33609
2 EX-1.1 d80000dex11.htm EX-1.1 193809
3 EX-5.1 d80000dex51.htm EX-5.1 8352
4 EX-99.1 d80000dex991.htm EX-99.1 7206
5 EX-99.2 d80000dex992.htm EX-99.2 7547
9 GRAPHIC g80000g1112052616007.jpg GRAPHIC 2535
10 GRAPHIC g80000g1112052915419.jpg GRAPHIC 2535
11 GRAPHIC g80000g1112053002467.jpg GRAPHIC 4592
12 GRAPHIC g80000g1112053016279.jpg GRAPHIC 4583
  Complete submission text file 0001193125-25-275721.txt   451108

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ino-20251111.xsd EX-101.SCH 2831
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20251111_lab.xml EX-101.LAB 17993
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20251111_pre.xml EX-101.PRE 11249
22 EXTRACTED XBRL INSTANCE DOCUMENT d80000d8k_htm.xml XML 3642
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 251468387
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)